作者
Kamil Kuca, Daniel Jun, Jiri Cabal, Martina Hrabinova, Lucie Bartosova, Veronika Opletalova
发表日期
2006/4
期刊
Basic & clinical pharmacology & toxicology
卷号
98
期号
4
页码范围
389-394
出版商
Blackwell Science, Ltd
简介
Organophosphorus compounds such as nerve agents inhibit, practically irreversibly, cholinesterases by their phosphorylation in the active site of these enzymes. Current antidotal treatment used in the case of acute nerve agent intoxications consists of combined administration of anticholinergic drug (usually atropine) and acetylcholinesterase (AChE, EC 3.1.1.7) reactivator (HI‐6, obidoxime, pralidoxime), which from a chemical view is a derivative from the group of pyridinium or bispyridinium aldoximes (commonly called “oxime”). Oximes counteract acetylcholine increase, resulting from AChE inhibition. In the human body environment these compounds are powerful nucleophiles and are able to break down the bond between AChE and nerve agent molecule. This process leads to renewal of enzyme functionality – to its reactivation. The usefulness of oxime in the reactivation process depends on its chemical …
引用总数
200620072008200920102011201220132014201520162017201820192020202120222023284622125232422
学术搜索中的文章
K Kuca, D Jun, J Cabal, M Hrabinova, L Bartosova… - Basic & clinical pharmacology & toxicology, 2006